On Wednesday, January 8, 2025, Cathie Wood-led ARK Invest made significant portfolio adjustments.

The firm sold shares of DraftKings Inc and made notable purchases in Illumina Inc and Intellia Therapeutics Inc.

The DraftKings Trade: ARK Invest, through its ARKF fund, divested a total of 40,801 shares of DraftKings Inc. With shares closing at $38.35, the sale amounted to approximately $1.57 million.

The Illumina Trade: On the same day, ARK Invest increased its stake in Illumina Inc. The ARKG and ARKK funds collectively acquired 9,320 shares, translating to an investment of around $1.3 million, given Illumina’s closing price of $139.68.

This purchase underscores ARK’s confidence in the genomic sequencing market, where Illumina is a leading player.

The Intellia Trade: ARK Invest also made a strategic purchase of Intellia Therapeutics Inc shares. The ARKG and ARKK funds bought a combined total of 100,099 shares, valued at approximately $1.2 million based on the closing price of $12.02. Intellia is known for its advancements in CRISPR gene editing technology, a field ARK has been bullish on due to its potential to revolutionize healthcare.

Other Key Trades:

  • Sold 101,854 shares of Roblox Corp, valued at approximately $6.3 million, reflecting a strategic shift in ARKK’s gaming sector investments.
  • Purchased 653,091 shares of Recursion Pharmaceuticals Inc, totaling about $4.7 million, highlighting continued interest in AI-driven drug discovery.
  • Sold 63,523 shares of Archer Aviation Inc, worth around $666,000, indicating a reevaluation of its position in the urban air mobility market.
  • Bought 608,900 shares of Absci Corp, valued at approximately $2 million, reinforcing ARK’s focus on innovative biotech firms.

Planning your financial journey can be daunting but it doesn't have to be. Fire Fast by Dzambhala helps you understand and plan effectively.

Join the vibrant privacy-ensured Dzambhala community on

#Biotech